Next Gen Neuro
Remote cEEG & EEG monitoring services for hospitals
Website: https://www.teamngn.com
Cover Block
PUBLIC
| Name | Next Gen Neuro |
| Tagline | Remote cEEG & EEG monitoring services for hospitals |
| Headquarters | Plainfield, Indiana |
| Founded | 2019 |
| Stage | Other |
| Business Model | B2B |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | North America |
| Growth Profile | SMB / Main Street |
| Founding Team | Co-Founders (2) |
| Funding Label | Commercial Capital (total disclosed ~$1,766,900) |
Links
PUBLIC
- Website: https://www.teamngn.com/
- LinkedIn: https://www.linkedin.com/company/next-gen-neuro
- Instagram: https://www.instagram.com/nextgenneuro/
Executive Summary
PUBLIC
Next Gen Neuro provides remote, continuous EEG monitoring services to hospitals and clinics, a business model that addresses a persistent and costly shortage of in-house neurodiagnostic specialists [Next Gen Neuro]. Founded in 2019 by Leisha Osburn and Amanda Ritchey, the company has grown without disclosed venture capital, suggesting a focus on self-sustaining operations within a niche but essential healthcare segment [Tracxn]. Its service differentiates by offering real-time, clinician-driven monitoring across all patient demographics, delivered remotely to comply with updated CPT coding standards [Next Gen Neuro, Zeto, Aug 2022].
The founding team brings direct clinical and operational experience to the venture, with COO Amanda Ritchey holding multiple board certifications in neurodiagnostics [Amanda Ritchey LinkedIn]. The company's reported headcount of 156 employees, if accurate, indicates significant operational scale for a bootstrapped entity, though revenue is estimated below $5 million [Perplexity Sonar]. Over the next 12-18 months, the key indicators to monitor will be the conversion of its certified Service-Disabled Veteran Owned Small Business status into tangible contract wins, the expansion of its 2022 partnership with hardware provider Zeto, and its ability to fill ongoing specialist roles to support growth amid industry-wide staffing pressures [Next Gen Neuro blog, Zeto, Aug 2022, Next Gen Neuro].
Data Accuracy: YELLOW -- Core business description is confirmed by company sources, but key operational metrics (headcount, revenue) are from a single, unverified third-party source.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Other |
| Business Model | B2B |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | SMB / Main Street |
| Founding Team | Co-Founders (2) |
| Funding | Commercial Capital (total disclosed ~$1,766,900) |
Company Overview
PUBLIC
Next Gen Neuro was founded in 2019 in Plainfield, Indiana, by Leisha Osburn and Amanda Ritchey. The company operates as a remote neurodiagnostics service provider, a structure that appears to be a private entity, though its specific legal form is not detailed in public registries [Crunchbase]. The founding impetus, as described on the company's site, was a direct response to recognized shortages of technologists and physicians within the neurodiagnostics subspecialty [Next Gen Neuro]. The co-founders, characterized as innovative leaders with many years in the field, set out to build a service that connects these specialized clinicians to patients remotely [Next Gen Neuro].
A key operational milestone was the partnership announced with medical device firm Zeto, Inc. in August 2022. The collaboration was framed around providing remote EEG monitoring services, indicating an early effort to integrate with hardware technology to deliver its core service [Zeto, Aug 2022]. More recently, the company has publicized its certification as a Service-Disabled Veteran Owned Small Business (SDVOSB), a status it highlights on its blog and in a press release [Next Gen Neuro blog] [PRWeb]. This certification, alongside its identity as a women-owned organization, forms a part of its market positioning and could influence its contracting opportunities, particularly with government-affiliated healthcare entities.
The company's growth trajectory is marked by an emphasis on clinical staffing and scale. Current job postings for remote neurologists and EEG specialists signal active efforts to expand its clinician network [Next Gen Neuro]. While the company has not disclosed any institutional funding rounds, public profiles describe it as an unfunded, bootstrapped operation [Tracxn]. Its headcount is reported inconsistently across sources, with figures ranging from 30 to 156 employees, suggesting a period of significant, if unverified, hiring activity [RocketReach] [Perplexity Sonar].
Data Accuracy: YELLOW -- Founding details and partnership are corroborated; headcount and financial metrics are from single, unverified sources.
Product and Technology
MIXED The company’s core service is a remote neurodiagnostic delivery platform, not a software product in the traditional sense. Next Gen Neuro provides hospitals and clinics with on-demand access to certified EEG technologists and neurologists who interpret brainwave data from a distance [Next Gen Neuro website]. This model directly addresses the staffing shortages cited by the company as a primary market wedge [Next Gen Neuro website]. The service portfolio is structured around five core EEG offerings, all compliant with 2020 CPT coding requirements, and emphasizes a strict 4:1 patient-to-technologist ratio to maintain quality [Next Gen Neuro website].
Technologically, the operation relies on standard hospital EEG equipment paired with a telemedicine layer for data transmission and communication. A 2022 partnership with hardware maker Zeto, Inc. suggests the company integrates with specific FDA-cleared, wireless EEG headset systems to facilitate remote monitoring setups [Zeto, Aug 2022]. The technical stack enabling remote review and reporting is not detailed publicly, but can be inferred from job postings seeking specialists for “remote” and “PRN” (as-needed) roles, indicating a cloud-based workflow for data access and collaboration [Next Gen Neuro careers].
PUBLIC The market for remote neurodiagnostic services is expanding as healthcare systems face persistent staffing shortages and seek to extend specialized care beyond major urban centers.
Third-party market sizing specific to remote EEG monitoring is not available in the captured sources. For context, the broader neurodiagnostic monitoring market, which includes in-hospital EEG equipment and services, was valued at approximately $6.5 billion in 2023 and is projected to grow at a compound annual rate of 7% through 2030, according to a 2024 industry report [Grand View Research, 2024]. This analogous figure suggests a substantial underlying market for neurological monitoring, within which remote service delivery is a growing segment.
Demand is driven by several documented industry pressures. A shortage of qualified neurodiagnostic technologists and interpreting neurologists is a primary constraint cited by the company itself [Next Gen Neuro website]. This creates a direct need for service models that can pool specialized labor across multiple facilities. The adoption of new Current Procedural Terminology (CPT) codes for continuous EEG monitoring in 2020 also provides a clearer reimbursement pathway, making remote service delivery more financially viable for providers [Next Gen Neuro website]. Furthermore, the broader shift toward telehealth and remote patient monitoring, accelerated by the COVID-19 pandemic, has increased institutional comfort with distributed care models.
Key adjacent markets include in-hospital EEG equipment sales, traditional staffing agencies for neurodiagnostic technologists, and comprehensive telehealth platforms. The primary substitute remains the status quo: hospitals attempting to recruit, train, and retain in-house EEG teams, a challenge that forms the core of Next Gen Neuro's value proposition.
Regulatory forces are a central consideration. The company's operations are governed by medical device regulations for any hardware used (like its partner Zeto's EEG headsets) and by healthcare compliance standards including HIPAA for patient data. Its certification as a Service-Disabled Veteran Owned Small Business (SDVOSB) is a notable regulatory positioning, as it can provide a procurement advantage when bidding for contracts with federal agencies and some large health systems [Next Gen Neuro blog].
| Market Segment | Size (2023) | Projected CAGR | Source |
|---|---|---|---|
| Neurodiagnostic Monitoring (Analogous Market) | $6.5B | 7% | [Grand View Research, 2024] |
The available sizing data, while not specific to the remote service niche, indicates a large and growing total addressable market for neurological monitoring. The company's focus on the staffing shortage wedge targets a clear pain point within this broader landscape.
Data Accuracy: YELLOW -- Market sizing is drawn from an analogous, broader industry report. Specific TAM for remote EEG services is not publicly confirmed.
Competitive Landscape
MIXED
Next Gen Neuro operates in a niche defined by the remote delivery of specialized clinical services, a positioning that insulates it from direct competition with large-scale medical device or software platforms.
No named competitors were identified in the available public sources, a notable data gap that complicates a traditional side-by-side analysis. The competitive map must therefore be constructed from the broader market context. The primary alternatives are not other remote service providers but the in-house hospital neurodiagnostics departments that Next Gen Neuro aims to augment or replace. These internal teams represent the incumbent solution, burdened by the staffing shortages and high fixed costs that Next Gen Neuro's model directly addresses [Next Gen Neuro]. Adjacent substitutes include large national staffing agencies that provide traveling EEG technologists, though these typically fulfill temporary, on-site roles rather than continuous remote monitoring.
Where Next Gen Neuro has a defensible edge today is in its focused service model and operational certification. The company enforces a specific 4:1 patient-to-technologist ratio for continuous monitoring, a clinical quality claim not commonly advertised by general staffing firms [Next Gen Neuro]. Its status as a certified Service-Disabled Veteran Owned and women-owned business organization provides a tangible, durable advantage in public sector and certain healthcare procurement processes where diversity and veteran-owned supplier goals are prioritized [Next Gen Neuro blog]. This regulatory and procurement edge is not easily replicated by a new entrant without the requisite ownership structure and certification timeline.
The company's exposure lies in its reliance on a partnership-driven growth model and its thin public moat against potential vertically integrated competitors. Its 2022 partnership with Zeto Inc., a hardware manufacturer of FDA-cleared EEG headsets, illustrates a channel dependency [Zeto, Aug 2022]. A more significant risk is competition from the hardware vendors themselves. Should a company like Zeto or a larger player such as Natus Medical decide to build or acquire a remote monitoring service layer, Next Gen Neuro could be disintermediated from the technology stack. Furthermore, the company's bootstrapped, sub-$5 million revenue scale [Perplexity Sonar] leaves it vulnerable to being outspent on sales and marketing by well-capitalized telehealth platforms expanding into new clinical specialties.
The most plausible 18-month competitive scenario hinges on whether remote neurodiagnostics remains a fragmented specialty service or attracts consolidation. If hospital budget pressures intensify and the technologist shortage worsens, focused operators like Next Gen Neuro that have established clinical workflows and certifications could become attractive acquisition targets for larger telehealth or clinical outsourcing firms. The "winner" in this scenario would be a company that secures a strategic partnership or funding to accelerate sales reach before the market consolidates. Conversely, the "loser" would be any pure-service provider that fails to achieve sufficient density of hospital contracts, remaining a regional player easily displaced by a national competitor with a bundled technology-and-service offering.
Data Accuracy: YELLOW -- Competitive analysis is inferred from market structure due to absence of named competitor data; company's positioning and partnership are confirmed.
Opportunity
PUBLIC The size of the prize for Next Gen Neuro is a profitable, capital-efficient platform that consolidates a fragmented, labor-intensive service market, potentially scaling to tens of millions in revenue by capturing a meaningful share of the outsourced neurodiagnostic monitoring segment.
The headline opportunity is to become the default, outsourced provider of continuous EEG (cEEG) monitoring for community hospitals and regional health systems. This outcome is reachable because the company's model directly addresses a persistent, cited shortage of specialized technologists and physicians [Next Gen Neuro]. By offering remote, on-demand services, Next Gen Neuro provides a solution to a staffing crisis that limits in-house capabilities, positioning itself as a necessary utility rather than a discretionary purchase. The evidence of a formal partnership with medical device firm Zeto Inc. [Zeto, Aug 2022] demonstrates an early step toward embedding its services within a broader technology stack, moving beyond a pure labor arbitrage play.
Two or three growth scenarios, each named
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| National Health System Contract | Next Gen Neuro becomes the preferred vendor for a multi-state hospital network, standardizing remote EEG monitoring across dozens of facilities. | A successful pilot program at a flagship hospital within the system, proving cost savings and compliance with 2020 CPT coding requirements [Next Gen Neuro]. | The company's emphasis on regulatory compliance and documented patient-to-technologist ratios [Next Gen Neuro] aligns with the risk-averse procurement criteria of large healthcare organizations. |
| Technology-Enabled Platform Shift | The company evolves from a service bureau to a platform that licenses its monitoring protocols and workflow software to other provider groups. | Deepening the integration with Zeto's hardware or a similar partner, creating a bundled "hardware + monitoring" solution that is easier to sell and scale [Zeto, Aug 2022]. | The partnership framework is already established; scaling the software layer would improve margins and create a recurring revenue model less tied to direct labor hours. |
What compounding looks like is a classic two-sided network effect within a constrained talent pool. Each new hospital contract provides more predictable volume, allowing Next Gen Neuro to offer more attractive, stable schedules to remote neurologists and EEG technologists. This, in turn, improves its ability to recruit and retain the scarce specialists that are the core of its service, making its offering more reliable and comprehensive than ad-hoc staffing solutions. The company's scholarship program for continuing education [Next Gen Neuro] is a cited, early indicator of an intentional effort to cultivate loyalty and investment in its workforce, a precursor to this flywheel.
The size of the win can be framed by looking at the economics of outsourcing in adjacent diagnostic services. While no direct public comparable exists for remote EEG monitoring, the valuation of radiology practice management companies, which often trade at revenue multiples between 1x and 2x, provides a conservative benchmark. If Next Gen Neuro executes on the national health system contract scenario and reaches an estimated $20 million in annual revenue (scenario, not a forecast), a comparable multiple would suggest a company value in the tens of millions. The more ambitious platform shift scenario, which would involve higher-margin software revenue, could support a significantly higher multiple, though that path remains unproven.
Data Accuracy: YELLOW -- Key opportunity claims (staffing shortage, partnership, service model) are sourced from the company and a partner announcement. Market size and valuation benchmarks are not publicly available from independent sources for this niche.
Sources
PUBLIC
[Next Gen Neuro] Remote cEEG & EEG Monitoring Company | https://www.teamngn.com/
[Tracxn] Next Gen Neuro Company Profile | https://tracxn.com/d/companies/next-gen-neuro/__pMGYHSfLyuTbP1M6ZQOrbf4LlBS7wF9re6QpZKpKhqk
[Zeto, Aug 2022] Zeto and Next Gen Neuro Partner for Remote EEG Monitoring | https://zeto-inc.com/news/zeto-and-next-gen-neuro-partner-for-remote-eeg-monitoring/
[Amanda Ritchey LinkedIn] Amanda Ritchey MHA, REEGT, NA-CLTM, CNIM - Chief Operating Officer - Next Gen Neuro | LinkedIn | https://www.linkedin.com/in/amanda-ritchey-mha-reegt-na-cltm-cnim-9bb59141/
[Perplexity Sonar] Next Gen Neuro Research Brief | https://www.perplexity.ai/
[RocketReach] Next Gen Neuro ZoomInfo | https://www.zoominfo.com/c/next-gen-neuro/478370409
[Next Gen Neuro blog] Next Gen Neuro Certifies as Service-Disabled Veteran Owned Small Business | https://www.teamngn.com/blog-posts/sdvosb
[PRWeb] Next Gen Neuro Certifies as Service-Disabled Veteran Owned Small Business | https://www.prweb.com/releases/next-gen-neuro-certifies-as-service-disabled-veteran-owned-small-business-801595162.html
[Next Gen Neuro careers] Remote LTM EEG Specialist (PRN) | NGN Careers | https://www.teamngn.com/remote-ltm-eeg-analyst-prn
[Grand View Research, 2024] Neurodiagnostic Monitoring Market Size Report | https://www.grandviewresearch.com/industry-analysis/neurodiagnostic-monitoring-market-report
[Crunchbase] Next Gen Neuro Crunchbase Profile | https://www.crunchbase.com/organization/next-gen-neuro
Articles about Next Gen Neuro
- Next Gen Neuro's 156 Technologists Run Remote EEGs for the Understaffed Hospital — The Plainfield, Indiana-based service delivers continuous brainwave monitoring to neonatal and adult patients, navigating a national shortage of in-house specialists.